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Complex cellular processes, such as phenotype decisionmaking, are exceedingly difficult
to analyze experimentally, due to the multiple-layer regulation of gene expression and
the intercellular variability referred to as biological noise. Moreover, the heterogeneous
experimental approaches used to investigate distinct macromolecular species, and their
intrinsic differential time-scale dynamics, add further intricacy to the general picture
of the physiological phenomenon. In this respect, a computational representation of
the cellular functions of interest can be used to extract relevant information, being
able to highlight meaningful active markers within the plethora of actors forming an
active molecular network. The multiscale power of such an approach can also provide
meaningful descriptions for both population and single-cell level events. To validate this
paradigm a Boolean and a Markov model were combined to identify, in an objective and
user-independent manner, a signature of genes recapitulating epithelial to mesenchymal
transition in-vitro. The predictions of the model are in agreement with experimental data
and revealed how the expression of specific molecular markers is related to distinct cell
behaviors. The presented method strengthens the evidence of a role for computational
representation of active molecular networks to gain insight into cellular physiology and
as a general approach for integrating in-silico/in-vitro study of complex cell population
dynamics to identify their most relevant drivers.
Keywords: computational modeling, epithelial-mesenchymal transition, cell decision, boolean model,
markov model
1. INTRODUCTION
The ability to evolve and adapt to changing environments is a fundamental characteristic of every
cell (Magyar et al., 2007; Balázsi et al., 2011) that exploits nested feedback loops, multistable
dynamics, and gene expression noise to generate complex regulatory networks (Elowitz et al., 2002;
Brandman et al., 2005; Ray and Igoshin, 2010; Tiwari et al., 2010). These processes are collectively
referred to as cell decision making and are fundamental for the survival of every organism, from
bacteria to humans (Magyar et al., 2007). In particular, the development of different observable
characteristics, like morphological traits or gene expression patterns, from an isogenic population
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defines a phenotypic decision making and it is exploited
in a number of different contexts, such as stem cells
differentiation (Morrison and Kimble, 2006), senescence (Oren,
2003), embryogenesis (Zernicka-Goetz et al., 2009), cancer
progression and metastasis formation (Zhang et al., 2014).
Epithelial to mesenchymal transition (EMT) is a notable
example of phenotypic cell decision making that consists in the
transdifferentiation of epithelial in mesenchymal cells (Lamouille
et al., 2014). While EMT is fundamental for the development
of complex organisms (Nieto et al., 2016) and for wound
healing (Margadant and Sonnenberg, 2009), it is also exploited
in pathological settings, such as induction of pharmacoresistance
(Pisco and Huang, 2015; Zheng et al., 2015), metastases
formation (Margadant and Sonnenberg, 2009; Nieto et al., 2016)
or fibrosis (Margadant and Sonnenberg, 2009). Indeed, increased
survival capabilities, motility, and fibrogenesis are hallmarks of
this transition, together with marked modifications in cell shape
and expression profile (Zhang et al., 2014), Figure 1.
The importance of the EMT and its numerous biological roles
have fostered a significant interest in the scientific community.
In particular uncovering the underlying molecular mechanisms
of this process is considered to be the key to its control
and to the treatment and prevention of pathological processes.
Traditional in-vitro assays, however, tend to be poorly equipped
for this task, as they are designed to quantify population
averages and are, therefore unable to evaluate intercellular
variability. This parameter is crucial for complex biological
processes, like phenotypic transitions, that initiate in a small
subset of cells before spreading to the rest of the population.
Computational strategies can be used to fill this gap, simulating
the behavior of large networks and allowing to infer the
response to complex stimuli (Andrieux et al., 2014), functionally
clusterize the behavior of each cell (Coquet et al., 2017) or
reconstruct developmental regulatory networks (Moignard et al.,
2015). Most of these models, however require large amounts
of quantitative data (Moignard et al., 2015) that might not be
available, or specific information for every interaction, (Andrieux
et al., 2014) that might restrict their applicability to a single
experimental model.
FIGURE 1 | Representative images of the epithelial (A) and mesenchymal (B) phenotypes in A549 cell line. The latter was induced through treatment with the
pro-fibrotic cytokine Transforming Growth Factor Beta 1, (TGF-β1, 5 ng/mL) for 48 h. Epithelial cells exhibit regular shapes and a high degree of spatial organization,
while mesenchymal ones are more variable, spindle-like and have a less organized structure.
Computational models can be exploited to identify the most
relevant markers for a process of interest (Huang et al., 2013;
Mak et al., 2016; Koplev et al., 2018) and drive its experimental
evaluation. These gene lists, however, are generally extracted
from experimental data and as such, tend to be highly dependent
on the dataset composition. Furthermore, the gene selection
methods often rely on the study of the correlation with the
expression of putative EMT markers (seeds) (Mak et al., 2016;
Koplev et al., 2018). As a consequence, they are not able to
identify genes that are connected with non-linear relations to the
seeds or that exhibit different gene expression trends in different
cell lines. Furthermore, the currently available gene signatures
include a high number of genes [33 in Huang et al. (2013),
77 in Mak et al. (2016), and 239 in Koplev et al. (2018)] that
might limit their applicability and hamper the interpretation of
the results.
In this study we describe a computational model of EMT that
integrates a transcriptional regulation network and a discrete
time Markov Chain (DTMC). This tool was developed to be
independent from a specific cell line and particular in-vitro
data. The signal transduction network was represented as a
boolean network (BN) (Wang et al., 2012), that can be used
to describe large networks and requires minimal information
to be defined. The DTMC (Gagniuc, 2017) was automatically
identified through the analysis of the stable states of the BN. This
architecture allows both to study the temporal evolution of the
different gene expression patterns (phenotypes) and to identify
the most relevant nodes for the network’s functioning. These
markers could be used to characterize EMT progression and aid
the interpretation of computational and experimental results.
Furthermore, this framework is not EMT specific and
relies solely on publicly available information. As such, it
could be effectively applied to other biological processes and
become a general approach for combining in-silico/in-vitro
study of complex cell population dynamics and identifying
their most relevant drivers. To further improve applicability
the code and the model are made freely available, both as
Supplementary Material (Data Sheet 2) and at http://www.
mcbeng.it/en/category/software.html
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TABLE 1 | Correspondences between Kegg interaction types and boolean
operations used in the BN.
Kegg interaction type Boolean operation
Activation MAJ
Binding/association AND
Complex AND
Dissociation AND
Expression MAJ
Inhibition MAJ
Missing interaction -
Remove -
2. MATERIALS AND METHODS
2.1. Definition of the Boolean Network (BN)
The BN was defined combining 24 signal transduction networks
downloaded through Cytoscape (cytoscape.org) from the KEGG
database (http://www.kegg.jp, Table S1). These maps were
selected as the ones that included at least six markers commonly
associated with EMT (Epithelial to Mesenchymal Transition
RT2 Profiler PCR Array, Qiagen) and were independently
converted in BNs, substituting each interaction type coded
in KEGG with a boolean operation. These correspondences
are reported in Table 1 where MAJ represents the majority
function, that determines a gene to be ON if most of its inputs
promote its activation, AND is the logical AND operation and
the last two interactions types were not considered for the
BN definition.
This representation is a radical simplification with respect
to the reality of gene expression regulation and might
not be thoroughly accurate, but it is generally applicable
to all the signal transduction pathways considered for this
analysis. Indeed, using different logical functions or diversifying
them would have required additional knowledge on each
pathway, that could not be available or be dependent on the
experimental model considered, thus reducing the applicability
of this framework and complicating the integration of the
different pathways.
The 24 logical networks extracted from the KEGG database,
were combined in a single graph, relying on the Entrez gene ID,
to uniquely identify each molecular component and effectively
combine its interactions in different pathways (as exemplified
in Figure S1). This resulted in a BN comprising 895 nodes
and 171 connected components (i.e., independent subgraphs)
identified using the algorithm proposed by Edelsbrunner and
Harer (2010). The latter analysis highlighted the presence of a
major subnetwork significantly larger (about 80 fold) than the
others (Table S2), that was considered to comprise all the relevant
regulations for the modeling of EMT in single cells.
The largest connected BN was analyzed to identify the most
important nodes for the network’s functioning. This step relied
on an automatic and objective procedure that calculates a
score based on two metrics commonly used for the analysis
of BNs. The first one is the number of exiting connections,
that quantifies the regulatory power of a gene through the
evaluation of the number of nodes it influences directly. The
second one is the eccentricity, that measures the centrality
of each gene (Equation 1) as the inverse of the longest
shortest distance between the current node and every other
element of the network. Eccentricity can be considered an
indication of the number of direct and indirect interactions
of each node.
E =
1
max(minPathLen)
(1)
As each of these two parameters spans different ranges, the
ranking (RGOD, R
G
E ) of each gene/complex with respect to either
parameter was used to calculate a score. This simple modification
ensures an equal contribution of the two metrics to the score.
While the application of the negative logarithm establishes
a direct correlation between this parameter and the node’s
importance (Equation 2).
SG = −log(R
G
OD + R
G
E ) (2)
This metric, computed for every node of the BN, was used to
isolate a small number of markers fundamental for the network’s
functioning, as modifications of their activities will extensively
impact the network’s dynamic behavior, and thus potentially
capable of recapitulating EMT in-vitro.
2.2. Definition of the Discrete Time Markov
Chain (DTMC)
A DTMC is defined by a set of states and a transition
matrix, that identifies the connections between the nodes
and their probability. Both these elements were determined
automatically, through a local search algorithm (Algorithm 1,
Figures S2A,B) capable of simulating the dynamic evolution
of the state of all the nodes in the BN. In particular, starting
from an initial condition defined as described in the next
paragraph, the value of each gene/ complex was updated
according to its interactions with the rest of the network
and the values of the other nodes. To simulate the presence
of processes with different rates, the order with which the
nodes were updated was defined randomly at each iteration
(function defineUpdateOrder in Algorithm 1). This procedure
is akin to asynchronous update but it constrains all the nodes
to be revised within the same iteration (Figure S2C). This
modification does not affect the single state attractors of the
network and is expected to provide almost equivalent results in
real-world networks.
A different determination of the initial condition was
implemented for the identification of either the nodes and
or the transition matrix of the DTMC. In the former
case a random configuration with a defined probability of
activation, varying between 0 and 100% in 5% steps, was
used. In the latter a perturbed version of each stable state
was considered. In particular the value of each gene was
modified with a 5% probability, that could be increased in
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Algorithm 1: DTMC Determination.
1: procedure DTMC-D(Network, PercActiveNodes, maxIter)
2: nodes←− number of nodes in the network
3: initialCondition←− defineInitialCondition(nodes/stable
state, PercActiveNodes/PercPerturbation)
4: change←− 1 ⊲ flag used to track changes in the nodes
configuration
5: iter←− 0 ⊲ index that keeps track of the number of
iterations
6: newState←− initialCond
7: while change == 1 — iter<maxIter do
8: newState←− oldState
9: updateOrder←− defineUpdateOrder(nodes)
10: for o in updateOrder do
11: newState←− updateNode(newState,o)
12: end for
13: iter←− iter+1
14: if oldState==newState then ⊲ The configuration
hasn’t changed
15: change←−0
16: end if
17: end while
18: return newState
19: end procedure
5% steps in case the steady state reached at the end of the
simulation was equal to the starting one. This procedure was
iterated until either a new attractor was found or the flipping
probability reached 100%. This strategy doesn’t closely mirrors
the behavior of a real population of cells, nor reproduces
faithfully specific configurations recognizable in-vitro but allows
for a much more extensive characterization of the dynamic
behavior of the network while maintaining generality and user-
independence.
A total of 80 · 104 simulations were performed (40 ·
104 for the determination of the steady states and 40 · 104)
for the identification of the transition matrix. This number
is significantly higher than that considered in similar works
(Albert et al., 2008; Schwab et al., 2017) and it was chosen
to account for the larger state space and maintain sampling
accuracy. In both cases finding an attractor or reaching the
maximum number of iterations (1 · 105) was considered as a
stopping criterion. During the determination of the transition
matrix, a small number of simulations (about 10%) identified
stable configurations that were not among the previously
identified states of the DTMC. In these cases the end state
was modified, so as to become equal to the node with the
closest configuration for whom the edges has been determined.
This modification was shown to always affect just one gene
of the BN.
2.3. Simulation of the DTMC
The DTMC was simulated applying Equation 3 where si,
represents the fraction of the population exhibiting phenotype i,
pjk is the probability of transition from state j to state k, and t is
the current iteration.


s1(t + 1)
s2(t + 1)
...
sn(t + 1)

 =


p11 p12 p13 . . . p1n
p21 p22 p23 . . . p2n
. . . . . . . . . . . . . . .
pn1 pn2 pn3 . . . pnn

 ·


s1(t)
s2(t)
...
sn(t)

 (3)
The initial condition, that is the prevalence of each phenotype
at the beginning of the simulation, was identified using publicly
available RNA sequencing (RNA seq) data (Mishra et al.,
2017) (available at https://www.ncbi.nlm.nih.gov/geo/ accession
number GSE90566). In this study EMT is induced through the
supplementation of 5 ng/mL of TGF-β1 for 72 h and its effects
were evaluated in two cancer cell lines (a human non small
cell lung cancer, A549 and a pancreas ductal adenocarcinoma,
Panc1). These experimental results were here used to define
the number of cells expressing each marker of the signature,
that was considered to be proportional to the mean number of
reads normalized by sequencing depth (baseMean). The gene
characterized by the highest mRNA level (baseMean value)
was assigned a random prevalence between 50 and 100%,
determining the number of cells expressing every other marker
as the fraction of this number maintaining the baseMean ratio.
These thresholds were combined with an iterative procedure
to identify 1,000 virtual populations of epithelial cancer cells
undergoing TGF-β1-induced EMT, whose patterns of expression
were coherent with the RNA seq data.
These populations of TGF-β1 expressing cells, that were
simulated until steady state, and the results of this analysis
were compared to experimental data acquired in comparable
conditions, to validate the model. At the same time the DTMC
was used to simulate single phenotypes and to determine their
contribution to the macroscopic behavior observed in-vitro.
2.4. Cell Culture and Real-Time
Quantitative PCR Data
In addition to the RNA Seq data presented inMishra et al. (2017),
the level of expression of the signature genes was also evaluated
with real-time quantitative polymerase chain reaction (qPCR).
These experiments were specifically performed to validate this
computational framework inducing A549 cells with TGF-β1 (5
ng/mL for 72 h). A549 cells (American Type Culture Collection
- ATCC, Manassas, VA, USA) were cultured in Dulbecco’s Eagle’s
Modified Medium (DMEM, Pan-Biotech GmbH, Aidenbach,
Germany) supplemented with 10% fetal bovine serum, 100 U/mL
penicillin, 100 g/mL streptomycin and 2 mM L-glutamine (all
from EUROCLONE S.p.A., Pero, MI, Italy), and maintained
at 37◦C in a humidified 5% CO2 incubator (Thermo Fisher,
Waltham, MA, USA). Cells were seeded at a density of 24
× 104 cells/cm2, 24 h prior to TGF-β1 (Peprotech, London,
UK) administration.
To isolate total RNA, cells were washed with PBS and scraped.
Cell pellets were then resuspended in 1mL of PureZOLTM
(Bio-Rad, Segrate, MI, Italy) and a standard protocol was
applied. RNA was treated with DNAse I (Sigma-Aldrich,
Milan, Italy) according to manufacturer instructions. 500
ng of total RNA was then retro-transcribed into cDNA
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with the iScriptTM cDNA Synthesis Kit (Bio-Rad, Segrate,
MI, Italy) and diluted 1:10. cDNA was then amplified by
qPCR using the SsoAdvancedTM SYBRr Green Supermix
(Bio-Rad, Segrate, MI, Italy) and KiCqStartr SYBRr Green
Primers (H_B2M_1, H_GAPDH_1, H_CDH1_1, H_VIM_1,
H_COL1A1_2, H_EGFR_1, H_ITGB1_1, H_MAPK1_1,
H_BAMBI_1, H_CBLC_1, H_FOXO6_1, and H_TLR2_1 from
Sigma-Aldrich, Milan, Italy).
The CFX ConnectTM Real-Time PCR Detection System (Bio-
Rad, Segrate, MI, Italy) was used to apply the following 2-step
thermal-cycling protocol: 95oC for 3 min, followed by 40 cycles
of 95oC for 15 s and 60oC for 30 s. A melting step between
95 and 65 oC was also included. Data analysis was conducted
using the CFX ManagerTM Software (Bio-Rad, Segrate, MI,
Italy), creating a gene study that uses an inter-run calibrator
to normalize the variability among the experiments. A total of
three independent biological replicates performed in technical
duplicates were performed.
3. RESULTS
3.1. Definition of the Boolean Model
The computational model of EMT was defined using the
hierarchical algorithm summarized in Figure 2. Its first step
was the definition of a boolean model (BN) describing the
relationships among the genes that are potentially involved in
this phenotype transition. Boolean models associate a binary
variable to each gene (node) and a Boolean operation to each
connection (edge). In this case a logical AND was used to model
the formation of complexes, thus associating an ‘on’ state with the
presence of all the composing proteins. Gene regulation, on the
other hand, was represented with the majority (MAJ) rule; i.e., a
gene is set to one when most of its inputs induce activation.
This formalism was chosen because it requires a minimal
set of information (only the logical relationships among the
components) to be defined and, as a consequence, it can be
generally applied to all the considered pathways, and to biological
processes not entirely characterized. This characteristic is
particularly relevant as introducing process-specific information
(i.e., using different representations for the same kind of reaction
in different pathways) might tie the BN to a specific experimental
model or condition. Indeed, the purpose of this initial step was to
include as much information as possible into the computational
model and to provide a general description of the EMT in a
wide range of experimental models and conditions. As such,
the KEGG database (http://www.kegg.jp) was interrogated to
identify, the signal transduction networks including a relevant
number of EMT markers (details in Methods section). This
database contains more than 500 representations of signal
transduction pathwaysmanually curated by experts, that describe
the interactions among gene products (proteins and RNA)mostly
independently of the experimental model.
These signal transduction networks were then combined
into a BN (Figure S1) whose analysis revealed the presence
of a main connected component, accounting for 78% of the
nodes, and several other independent subgraphs of much
FIGURE 2 | Flowchart describing the main steps of the computational method
here described.
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FIGURE 3 | Distribution of the scores computed for every node of the EMT
network. As this metric is proportional to the importance of the corresponding
node, the genes with a score above –2.5 were considered as part of the
signature.
smaller size (Table S2). As complex processes such as the
EMT are characterized by the interaction of multiple regulatory
mechanisms, we decided to disregard the smaller networks and
focus on the major connected component of the BN, comprising
700 nodes and 1,364 edges.
3.2. Determination of the DTMC and of the
Gene Signature
As shown in Figure 2, the BN was analyzed to determine the
nodes and edges of the DTMC. This was achieved through the
determination of the BN stable states and of the system’s response
to a perturbation of sufficient amplitude.
Attractors of length 1 have been previously associated with
the phenotypes that a cell can assume (Kauffman, 1969a,b)
and consequently to the nodes of a Markov chain describing
the process of interest (Gupta et al., 2011; Chu et al., 2017).
Concurrently a slight change in the expression profile of an
attractor can be used to determine its connections to the other
states of the DTMC and their probability.
To this aim, a local search algorithm (Algorithm 1) was
implemented and used to identify the stable states with the largest
basin of attraction. This strategy is particularly convenient for
networks like the one considered here, that are characterized by
a mostly unidirectional flow of information. This feature is likely
to reduce cyclic attractors, since the number of feedbacks capable
of leading the system to a previously visited configurations is very
low. Additionally, this approach does not constrain the size of the
network and allows for the simulation of processes with different
temporal dynamics within the network.
The initial condition was set randomly and characterized by
the probability of activation of each node that was varied between
0 and 100% with 5 % increments. This strategy was chosen for its
generality and lack of hypotheses on the modeled system. Indeed
setting specific initial conditions for the BN is likely to introduce
TABLE 2 | Signature genes determined to be significant for the behavior of the
network and used to reduce the stable states.
Gene Note
BAMB1 Pseudoreceptor of the TGFβ pathway whose function might be to limit
the signaling range of the TGFβ family.
CBLC Member of the Cbl family of E3 ubiquitin ligases that plays an important
role in cell signaling. Its expression might be restricted to epithelial cells.
EGFR Receptor for members of the epidermal growth factor family.
ERBB2 Member of the epidermal growth factor receptor family. While it does
not have a ligand binding domain it acts as a stabilizer for the
interaction between other receptors and ligands of the same family.
Overexpression of this gene has been reported in numerous cancers.
FOXO6 Transcription factor, generally localized in the nucleus and elevant
marker for the regulation of cancer development (e.g., lung and gastric
cancer), whose effect has been shown to be context dependent
(Jacobs et al., 2003; Qinyu et al., 2013; Hu et al., 2015).
ITGB1 Membrane receptor involved in cell adhesion and a variety of
processes like embryogenesis, tissue repair, immune response and
metastatic diffusion of tumor cells.
MAPK1 Kinase that integrates multiple biochemical signals, and is involved in a
wide variety of cellular processes, such as proliferation, differentiation,
transcription regulation and development.
TLR2 Receptor involved in pathogen recognition and activation of the innate
immunity.
constraints on its dynamic behavior, that might not be valid for
all the experimental models of interest.
The number of stable states determined by this analysis, was
of the same order of magnitude of the initial conditions. While
this is to be expected, given the size of the network and the wide
range of initial conditions, it prevents ameaningful analysis of the
results and the determination of the population’s behavior. For
this reason an automatic and objective procedure to identify the
most relevant nodes for the network’s functioning was developed.
This method relies on a score that combines two topological
indices commonly used for the analysis of BNs (Equation 2) and
was used to quantify the dependence of the paths within the
network on the presence of each node.
Computing the index in Equation 2 for every node of the
network led to the distribution of scores in Figure 3, that is
characterized by two distinct populations. The former is the most
numerous and comprises all the nodes with score below –2.5,
while the latter includes the genes/complexes with the highest
scores (above –2.5) and thus with the highest importance for the
BN. These were considered as signature markers and are reported
in Table 2, together with a short description of their function.
Although most of them are not commonly reported EMT
markers, their behavior is strictly connected to the hallmarks of
this transition, such as proliferation, cancer progression, tissue
repair, immune response, and differentiation.
This list was completed with the addition of TGF-β1, widely
used as an inducer to study the EMT in-vitro. The presence of this
inducer was used to trigger the EMT in the DTMC (section 3.3).
The pattern of expression of the signature genes was used to
merge the attractors previously determined for the BN into a
small number of states (Figure S3). This step led to an almost
800-fold reduction in the number of stable configurations and the
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definition of the DTMC states shown in Figure S4 (total number
of nodes 485).
Successively the transition matrix of the DTMC was
determined through the simulation of the BN starting from a
slightly perturbed version of each attractor. This perturbation,
implemented by flipping the value of each gene with a defined
probability, induces the transition between two stable states
and thus identifies the connections among the phenotypes. As
detailed in the material and methods section, this analysis,
considered a starting flipping probability of 5%, that could be
progressively increased, with 5% steps, if the perturbation did not
trigger a transition toward another state.
After the simulation of all the fixed points, the probability of
occurrence of each transition was determined as in Equation 4,
where N
j
i is the number of transitions recorded from state i to
state j and Ni is the total number of transitions exiting state i.
P
j
i =
N
j
i
Ni
·
1
d
j
iI
i
j
(4)
In this formulation the frequentist approach, that considers
a uniform probability distribution for the transition rates,
was combined with a correction factor aimed to increase the
biological accuracy of the model. The relative frequency of
each transition was divided by the distance between the two
phenotypes (d
j
i) and the average length of the corresponding
simulations (I
j
i). This operation favors the connections between
similar stable states without imposing a threshold on the
maximum number of genes that can vary at the same
time. Concurrently, this correction increases the probability of
transitions associated with shorter simulations, which have often
been shown to be the most probable in a biological setting
(Flöttmann et al., 2012). The results of this analysis defines the
transition matrix of the DTMC, that were then used to infer the
dynamics of gene expression patterns in a population of cells
undergoing the EMT.
3.3. Model Validation
To ensure the effectiveness of the model in reproducing the
EMT, the equivalence between its results and experimental data
acquired in comparable conditions has been verified. To this aim
the DTMC was used to simulate EMT in two cancer cell lines
(A549 and Panc1). The results of the simulations were compared
with RNA seq data originally presented in Mishra et al. (2017)
and freely available at NCBI GEO (accession number GSE90566).
Additionally qPCR data acquired ad-hoc were considered for the
lung cancer cell line A549. The DTMCwas simulated considering
2,000 virtual populations, initialized as described in the material
and methods section and accounting for a significantly larger
cardinality than a population generally employed for an in-
vitro assays (∼ 12.4 × 106 cells for A549 and ∼15.7 × 106
cells for Panc1 cells). This analysis determined the changes in
each phenotype prevalence throughout the EMT and thus the
variations in the number of cells expressing each marker of the
signature. These results were represented as the logarithm in base
2 of the fold change from the initial condition (FC, Equation 5),
that is directly comparable with the corresponding experimental
values and allows to easily distinguish between overexpressed
(FC>0) and underexpressed markers (FC<0).
log2FGg = log2
RNA
g
M
RNA
g
E
(5)
Figure 4 reports the results of this analysis and particularly panels
A and B compare the FCs recorded in-vitro to the corresponding
simulated values. One of the signature genes (FOXO6) was
excluded from this analysis, since the corresponding mRNA level
was not recorded in Mishra et al. (2017) and was below the
qPCR’s detection threshold. The latter technique was also unable
to quantify the expression of CBLC and TLR2, that were however
evaluated in Mishra et al. (2017). As such the comparison
between the qPCR and the in-silico data was restricted to five
markers (BAMB1, CBLC, EGFR, ERBB2, ITGB1, MAPK1), while
for the RNAseq dataset all genes but FOXO6 were considered.
The computational model shows a remarkably good
agreement with the experimental data. In particular, the
concordance index, calculated as the fraction of markers with
the same variation sign between modeled and in-vitro data, is
100% for the qPCR and 71% for the RNA seq. This ability of the
model of predicting the direction of change of the tested genes
supports the efficacy of the proposed computational method,
that works independently on the studied cell line. Furthermore
the computational framework here presented was also able to
predict, with the same DTMC, the direction of variation of
markers that were shown to behave differently in the considered
cell lines (e.g., BAMB1, EGFR,MAPK1). This is a very important
characteristic of our model that greatly improves its range
of applicability.
When the RNAseq dataset was considered, however, two
markers for every experimental model were shown to behave
incoherently in-vitro and in-silico. One of these, CBLC, was
common to both cell lines while ERBB2 and ITGB1 were unique
to A549 and Panc1 cells respectively.
A possible explanation for these inconsistencies is the non-
linear relation between mRNA and protein levels. Indeed the
pathways in the Kegg database describe high level interactions
involving mostly proteins, while the experimental data used
for the validation of the model quantify mRNA. As post-
transcriptional gene expression regulation mechanisms and
mRNA degradation rates could disrupt the proportionality
between the level of transcript and the amount of active protein
present in the system, a small percentage of inconsistently
expressed genes is to be expected.
The discrepancy between the qPCR and RNA levels of ERBB2
(Figure 4A) on the other hand, could be caused by the low
basal expression level of this gene. Indeed in this condition,
stochasticity of gene expression and population composition
could induce important changes in the FC.
Despite these differences the in-silico results were shown to be
equivalent to the qPCR results and to have a very good agreement
with the RNA seq ones. Indeed all the data points obtained
with the former technique were localized within the 95% limit
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FIGURE 4 | Comparison between the model’s results and the in-vitro data. In (A) the log2FC recorded in A549 cells for each signature marker is reported both for the
in-vitro and the in-silico analyses. Different colors are associated with alternative experimental techniques or the model’s results. (B) is the same as in (A) but for the
Panc1 cells. In this case only the RNA seq data reported in Mishra et al. (2017) were considered. (C) Bland-Altman plot showing the relation between the absolute
difference of the in-silico and in-vitro data and their mean. Different colors and symbols identify different comparisons while the solid black line represents the average
of the values on the y axis (obtained considering only the RNAseq values). The dotted lines identify the 95% limit of agreement (again computed using only the RNAseq
data) and their distance from the solid line is 1.96·σ , where σ is the standard deviation of the absolute difference. (D) Same as in (C) but for the Panc1 cell line.
of agreement (Equation 6) of the respective Bland Altman plots
(dotted lines in Figure 4C), while only one marker for every cell
line (corresponding to CBLC for the A549 and TLR2 for the
Panc1) was outside of the 95% confidence interval when the RNA
seq was considered (Figures 4C,D).
LoA = |1silicovitro | ± 1.96 · σ
silico
vitro (6)
This analysis determined also the presence of an offset, as the
solid line corresponding to the average of the values on the y axis
is above 0. This fixed error can almost entirely be attributed to the
outliers (CBLC for A549 cells and TLR2 for Panc1 cells), as all the
other genes are characterized by significantly lower values.
The equivalence of the results obtained for the two considered
cell lines, highlights once more the independency of our
computational framework from the experimental model, and
thus its versatility and usefulness for the study of complex
biological processes.
3.4. Transient State Analysis
The final step of the analysis of the EMT model was the study
of the transient state, that is the evaluation of the different
paths that EMT can follow and of their dependence on the
initial configuration.
For this analysis the prototypal mesenchymal configuration,
determined setting to 1 the markers upregulated by
TGF-β1 induction and to 0 those downregulated
by this stimulus (Mishra et al., 2017) (Table 3), was
used as a reference point in the calculation of the
Jaccard-Needham distance.
This parameter was computed as in Equation 7, where TF
and TT are the numbers of genes that are respectively set
to 0 and 1 in both configurations, while FT is the number
of markers that are 1 in the test configuration and 0 in the
reference one.
JND =
TF + FT
TT + TF + FT
(7)
Frontiers in Genetics | www.frontiersin.org 8 June 2019 | Volume 10 | Article 575
Cortesi et al. In-silico Cell Decision Making
The temporal evolution of the average value of this parameter,
weighted on each phenotype prevalence, was used to track the
state of the simulation and summarize its distance from the
theoretical EMT endpoint.
The result of this analysis is reported in Figure 5, where the
Jaccard-Needham distance from the prototypal mesenchymal
configuration is shown to slightly decrease and stabilize
throughout the simulation. This is an indicator of a progression
of the phenotypic transition that is however associated with a
significant variability throughout its execution. This is probably
a consequence of the many different paths that cells undergoing
EMT can follow. Indeed as shown in Flöttmann et al. (2012);
Wang et al. (2014) phenotypic transitions do not proceed linearly
from start to end through the same set of states, but are
composed of several different routes that can be influenced
and determined by many factors, including gene expression
stochasticity, variability in the microenvironment, differences
in cell cycle phase and epigenetic regulation. This aspect
complicates the analysis of biological processes, as population
averages become unsuited for the study of their intermediate
TABLE 3 | Theoretical mesenchymal states determined for the A549 and Panc1
cell lines.
A549 PANC1
BAMB1 1 0
CBLC 0 0
EGFR 1 0
ERBB2 0 0
ITGB1 1 1
MAPK1 1 0
TLR2 1 1
Upregulation and downregulation, as measured by Mishra et al. (2017) upon TGF-β1
stimulation, correspond to 1s and 0s, respectively.
phases. Computational tools can be particularly helpful in this
regard, since they allow to follow the behavior of each uniform
subpopulation independently.
The in-silico model of EMT was then used to simulate cell
populations composed of a single TGF-β1-expressing phenotype
and determine the path associated with their transformation
and the corresponding effectiveness. The latter was quantified
as the variation, between the first and last iteration, in average
Jaccard-Needham (Jaccard, 1901) distance from the theoretical
mesenchymal state (the same used for the A549 cell line),
weighted on the prevalence of each phenotype.
Of the 234 TGF-β1 expressing phenotypes, 8 were associated
with a high transformation efficiency, defined as a difference
in the Jaccard-Needham distance above 40%. The analysis of
the expression pattern of these states led to the identification
of 4 couples of phenotypes that differ only for the value of
FOXO6 (Table 4).
Their behavior is reported in Figure 6, where the effect of the
activation of FOXO6 is highlighted. In particular, the phenotypes
not expressing this marker are associated with a short transient
state and little or no oscillations, while the activation of this
gene, combined with the expression of either CBLC (Figure 6B)
or ERBB2 (Figure 6C), generates important non-monotonic
variations of the Jaccard-Needham distance and a consistent
increase in the number of iterations required to reach the steady
state. The expression of The expression of both CBLC and
ERBB2 (Figure 6D) is associated with an enhancement of this
phenomenon that appears also when FOXO6 is off, albeit with a
shorter dynamic.
Even though FOXO6 is a poorly studied marker within
the EMT framework, partly due to its low expression level in
the cellular models commonly used to study this phenomenon
(i.e., TGF-β1-induced A549 cells), this computational analysis
suggests it might have an important role in increasing the
variability among the population and generating the different
EMT paths. Its contribution, however, is potentially difficult
FIGURE 5 | Average Jaccard-Needham distance between the 10% most expressed phenotypes and the theoretical mesenchymal state (Table 3). The error bars
represent the standard error. In (A) the results of A549 cells are reported, while (B) shows the Panc1 data.
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TABLE 4 | Expression patterns of the phenotypes associated with the highest EMT efficiency.
Couple Phenotype TGFβ1 BAMB1 CBLC EGFR ERBB2 FOXO6 ITGB1 MAPK1 TLR2
1
7 1 0 0 0 0 0 0 0 0
248 1 0 0 0 0 1 0 0 0
2
13 1 0 1 0 0 0 0 0 0
291 1 0 1 0 0 1 0 0 0
3
24 1 0 0 0 1 0 0 0 0
348 1 0 0 0 1 1 0 0 0
4
77 1 0 1 0 1 0 0 0 0
343 1 0 1 0 1 1 0 0 0
FIGURE 6 | Average Jaccard-Needham distance between the theoretical mesenchymal state and the populations generated through the simulations of single
phenotypes. The eight initial configurations associated with the largest variation of this parameter are shown and divided in 4 couples differing only for the value of
FOXO6 (Table 3). The traces in (A) describe the behavior of the first couple, phenotypes 7 and 248, while (B–D) refer to couples 2, 3, and 4, respectively. In all cases
cyan triangles indicate the results obtained in absence of FOXO6, while the orange circles represent the condition of active FOXO6.
to verify in-vitro, as it requires the identification of the
subpopulations of phenotypes and thus the evaluation of gene
expression patterns at single cell level.
4. DISCUSSION
This work presents a computational model of EMT, a biological
process that enhances the invasiveness of epithelial cells and
has thus been associated to cancer progression and metastasis
formation. The complexity of this phenomenon, that features
a large regulatory network and can proceed through a number
of different pathways, has hampered its understanding and
characterization through in-vitro assays. An in-silico study,
however, can overcome the limitations of the experimental
analysis and both consider large signal transduction networks
and determine the role of single regulatory units. Indeed
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while computational models represent an approximation of
the biological reality, their results could be used to direct the
experimental analysis and identify potential therapeutic targets.
In this study, specifically, a computational representation of
EMT has been presented. It comprises both a single cell and
a population level representations that were developed to be
generally applicable independently of the experimental model.
This choice might reduce the biological accuracy of the model,
as it disregards the differences among cell lines and radically
simplifies the regulation of gene expression. The presented tool,
however, was shown to be able of automatically identifying a
small set of regulatory keypoints whose patterns of expression
could recapitulate EMT progression. The latter was measured
as the average Jaccard-Needham distance from the prototypical
mesenchymal phenotype. This composite parameter, being
directly comparable with experimental data, was used to validate
the computational framework, through the comparison of its
results with both qPCR and RNA seq data. In both these cases
the model was able to reproduce accurately the experimental
results and was thus used to study how the different initial
configurations contribute to the generation of the macroscopic
behavior. This analysis identified 4 couples of phenotypes
associated with a decrease in the average Jaccard-Needham
distance from the mesenchymal state higher than 40% and
differing only for the expression of FOXO6. The comparison
of the paths followed by each element of the couple allowed
to determine the effect of this marker in EMT progression.
The activation of FOXO6, in particular, was shown to induce
an increase in phenotypic variability within the population that
resulted in oscillations in the average Jaccard-Needham distance
and a longer transient phase. FOXO6 is a transcription factor
mostly found in the nucleus (Jacobs et al., 2003; Link, 2019)
that has been recently linked to EMT as its silencing has been
associated with reduced cell proliferation, migration and invasion
in colon cancer cells, via the inhibition of PI3K/Akt/mTOR
pathway (Li et al., 2018). The role of this gene, however, has
been scarcely studied within EMT, partially due to its low
average expression in common experimental models of this
phenomenon. Furthermore it is worth noting that mRNA levels
are not always an indicator of protein activation, as translation,
post-translational modifications and protein localization can
affect this property. Finally the activation of FOXO6 was here
shown to increase inter-cellular variability, an aspect that might
be masked when evaluating population averages.
Population variability is emerging as a fundamental variable
for the analysis and interpretation of biological processes, whose
importance has been largely understated due to the technical
difficulties in its experimental evaluation. The integration
of in-silico and in-vitro approaches could be an effective
solution to bridge this gap and develop accurate, quantitative
methods for the evaluation of complex cellular phenomena
at single cell level. The method here proposed is not
EMT specific, relies solely on freely available information
and is user independent and highly automated. As such
its could potentially become a general approach for the
integration of computational and experimental methods and
the identification of the most relevant drivers of complex cell
population dynamics.
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